PROM1 and digestive system neoplasm: Using gastrointestinal tumor cells, Matsumoto et al. and Yang et al. further showed that mTOR inhibition increase the CD133+ subpopulation and trigger the conversion of CD133− to CD133+ population in vitro [92, 96].